Abstracts Archive - Page 2203 of 2425 - ACR Meeting Abstracts

Abstract Number: 689 • 2013 ACR/ARHP Annual Meeting
Subclinical Biventricular Systolic Function Is Impaired In Patients With Systemic Sclerosis: A Speckle Tracking-Based Echocardiographic Study
Sukru Taylan Sahin¹, Selen Yurdakul², Neslihan Yilmaz³, Yonca Cagatay³, Saide Aytekin¹ and Sule Yavuz⁴, ¹Cardiology, Istanbul Florence Nightingale Hospital, Cardiology, Istanbul, Turkey, ²Cardiology, Bilim University, Faculty of Medicine, Cardiology Department, Istanbul, Turkey, ³Department of Rheumatology, Bilim University Faculty of Medicine, Istanbul, Turkey, ⁴Rheumatology, Bilim University, Faculty of Medicine, Rheumatology Department, Istanbul, Turkey
Subclinical biventricular systolic function is impaired in patients with systemic sclerosis: A speckle tracking-based echocardiographic studyBackground/Purpose : Myocardial involvement is associated with poor prognosis in…
Abstract Number: 690 • 2013 ACR/ARHP Annual Meeting
Assessment Of The New American and European Classification Criteria For Systemic Sclerosis In The Norwegian Systemic Connective Tissue Disease and Vasculitis Registry
Anna-Maria Hoffmann-Vold¹, Torhild Garen², Oyvind Midtvedt¹ and Øyvind Molberg³, ¹Rheumatology, Oslo University Hospital, Oslo, Norway, ²Department of Rheumatology, Oslo University Hospital Rikshospitalet, Oslo, Norway, ³Oslo University Hospital, Oslo, Norway
Background/Purpose: To assess the newly established ACR/EULAR classification criteria for systemic sclerosis 1 (SSc) in a large Norwegian SSc registry cohort. Methods: The Norwegian systemic…
Abstract Number: 691 • 2013 ACR/ARHP Annual Meeting
Descriptive Review Of Morphea Subjects From a Single Cohort Center
Lesley Portugal¹, Muneera Naeem², Lakshmi N. Moorthy³ and Vivien M. Hsu⁴, ¹Medicine, Robert Wood Johnson Medical School, New Brunswick, NJ, ²Medicine, Mountainside Hospital, Montclair, NJ, ³Pediatric Rheumatology, Robert Wood Johnson Medical School-Rutgers University, New Brunswick, NJ, ⁴Rheumatology, RWJ Med Schl Scleroderma Prog, New Brunswick, NJ
Descriptive review of Morphea subjects from a single cohort center Background/Purpose: Morphea, or localized scleroderma, is an idiopathic, rare fibrotic skin disorder that may result…
Abstract Number: 692 • 2013 ACR/ARHP Annual Meeting
Characterization Of Lower Limb Cutaneous Ulcers In Systemic Sclerosis: The Analysis of 424 Lesions
Jelena Blagojevic^1,2, Guya Piemonte¹, Laura Benelli¹, Francesca Braschi¹, Ginevra Fiori¹, Felice Galluccio¹, Francesca Bartoli¹, Lorenza Busco³, Alberto Pignone³, Giulia Carnesecchi¹, Gemma Lepri⁴, Serena Guiducci¹ and Marco Matucci Cerinic¹, ¹Department of Biomedicine, Division of Rheumatology, University of Florence, Florence, Italy, ²Doctorate in Genetics, Oncology and Clinical Medicine, University of Siena, Siena, Italy, ³Department of Internal Medicine, University of Florence, Florence, Italy, ⁴Department of Internal Medicine, Section of Rheumatology, Transition Clinic, University of Florence, Florence, Italy
Background/Purpose: Cutaneous ulcers reppresent one of the most frequent complications in course of systemic sclerosis (SSc). They are often disabling and difficult to treat. The…
Abstract Number: 693 • 2013 ACR/ARHP Annual Meeting
Pulmonary Involvement In Mixed Connective Tissue Disease: Slow Progression After 10 Years Of Follow-Up
Leticia Kawano-Dourado¹, Olivia M Dias¹, Fernando U Kay², Thais E H Gripp², Paula S Gomes³, Ricardo Fuller⁴, Bruno G Baldi¹, Ronaldo A Kairalla¹, Carlos R R Carvalho¹ and M.Teresa C. Caleiro⁵, ¹Division of Pulmonology - Heart Institute (InCor) - Medical School, University of Sao Paulo, Sao Paulo, Brazil, ²Division of Radiology - Hospital da Clinicas - Medical School, University of Sao Paulo, Sao Paulo, Brazil, ³Division of Pulmonology, Hospital do Servidor do Estado de Sao Paulo, São Paulo, Brazil, ⁴Division of Rheumatology - Hospital das Clinicas - Medical School, University of Sao Paulo, São Paulo, Brazil, ⁵Division of Rheumatology - Hospital da Clinicas - Medical School, University of Sao Paulo, Sao Paulo, Brazil
Background/Purpose: Evaluate the progression of interstitial lung disease (ILD) in a 10-year period of a group of 53 MCTD patients previously evaluated 10 years ago.Methods:…
Abstract Number: 694 • 2013 ACR/ARHP Annual Meeting
Peripheral Bone Marrow-Derived Endothelial Progenitor Cells and N-Terminal Probrain Natriuretic Peptide in Scleroderma Mexican Patients With and Without Diastolic Dysfunction: A Preliminary Report
Jesús Sepúlveda^1,2, Olga Vera-Lastra³, Maria Pilar Cruz-Dominguez⁴, Laura Montiel-Cervantes⁵, Joaquín Gómez-León⁶, Luis Robles-Espinoza⁷, Ramón Lozano-Morales⁷, Sergio Mendoza-Alvarez¹, Rubiraida Molina-Aguilar⁵, Gabriela Medina⁸, Jorge Vela-Ojeda⁹ and Luis J. Jara¹⁰, ¹Internal Medicine, Instituto Mexicano del Seguro Social, Mexico City, Mexico, ²Unidad de Estudios de Posgrado, Universidad Nacional Autónoma de México, Mexico City, Mexico, ³Internal Medicine, MD, Mexico City, Mexico, ⁴Division of Research, Hospital de Especialidades Centro Medico Nacional La Raza., Mexico, DF, Mexico, ⁵Hematology Laboratory, Instituto Mexicano del Seguro Social, Mexico City, Mexico, ⁶Cardiology Department, Instituto Mexicano del Seguro Social, Mexico City, Mexico, ⁷Central Laboratory, Instituto Mexicano del Seguro Social, Mexico City, Mexico, ⁸CMN La Raza IMSS, Seris/Zachila s/n La Raza, Mexico City, Mexico, ⁹Instituto Mexicano del Seguro Social, Mexico City, Mexico, ¹⁰Research and Education, Hospital de Especialidades Centro Medico La Raza, México City, Mexico
Background/Purpose: Diastolic dysfunction (DD) in systemic sclerosis (SSc) is a marker of increased risk of death. The N-terminal pro-brain natriuretic peptide (NT-proBNP) is a neurohormone…
Abstract Number: 695 • 2013 ACR/ARHP Annual Meeting
Combined Pulmonary Fibrosis and Emphysema (CPFE) In Systemic Sclerosis
Nicolas Champtiaux¹, Vincent Cottin², Eric Hachulla³, Dominique Valeyre⁴, Hilario Nunes⁵, David Launay⁶, Alice Berezne⁷, Bruno Crestani⁸, Loic Guillevin⁹, Jean-Francois Cordier² and Luc Mouthon¹⁰, ¹Service de Médecine Interne, hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France, ²Division of Pneumology, Hôpital Louis-Pradel, Hospices Civils de Lyon, Lyon 1, Lyon, France, ³Internal Medicine, Lille CEDEX, France, ⁴Department of Pneumology, Avicenne hospital (APHP), Bobigny, France, ⁵Department of Pneumology, Avicenne Hospital (AP-HP), Bobigny, France, ⁶Internal Medicine, Claude Huriez University Hospital, Lille, France, ⁷Paris Descartes University, Internal Medicine department, Cochin Hospital, Paris, France, ⁸Pneumology A, Hôpital Bichat, Paris, France, ⁹Internal Medicine, Cochin University Hospital, Paris, France, ¹⁰Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, Paris, France
Combined pulmonary fibrosis and emphysema (CPFE) in systemic sclerosis Background/Purpose: Combined pulmonary fibrosis and emphysema (CPFE) is a recently defined syndrome, in which centrilobular and/or…
Abstract Number: 696 • 2013 ACR/ARHP Annual Meeting
Chronic Periaortitis With Thoracic Aorta Involvement: A New Subtype Of Large Vessel Vasculitis
Alessandra Palmisano¹, Maria Letizia Urban², Domenico Corradi³, Federico Alberici⁴, Carlo Salvarani⁵, Carlo Buzio¹ and Augusto Vaglio⁶, ¹Clinical Medicine, Nephrology and Health Sciences, University of Parma, Parma, Italy, ²Nephrology University of Parma, Parma, Italy, ³Pathology University of Parma, Parma, Italy, ⁴Department of Clinical Medicine, Nephrology and Health Sciences, University of Parma, Parma, Italy, ⁵Rheumatology, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, ⁶Unit of Nephrology, University Hospital of Parma, Parma, Italy
Background/Purpose: Chronic periaortitis (CP) is characterised by a fibroinflammatory tissue arising from the adventitia of the abdominal aorta and the iliac arteries and spreading into…
Abstract Number: 697 • 2013 ACR/ARHP Annual Meeting
Longitudinal Assessment Of Pulmonary Function In 304 Norwegian Patients With Systemic Sclerosis
Anna-Maria Hoffmann-Vold¹, Torhild Garen², Oyvind Midtvedt¹, May-Brit Lund³, Jan Tore Gran¹ and Øyvind Molberg⁴, ¹Rheumatology, Oslo University Hospital, Oslo, Norway, ²Department of Rheumatology, Oslo University Hospital Rikshospitalet, Oslo, Norway, ³Pulmonary Unit, Oslo University Hospital, Rikshopitalet, Oslo, Norway, ⁴Oslo University Hospital, Oslo, Norway
Background/Purpose: The purpose of this study was to asses sequential pulmonary function measurements (forced vital capacity [FVC] % predicted) in a large systemic sclerosis (SSc)…
Abstract Number: 698 • 2013 ACR/ARHP Annual Meeting
Adverse Events With The Use Of Radiotherapy In Patients With Connective Tissue Diseases and Cancer: A Systematic Review and Meta-Analysis
Maria A. Lopez-Olivo¹, Juan A Martínez-López², Jean H. Tayar³, Mahesh Bavineni⁴ and Maria E. Suarez-Almazor⁵, ¹General Internal Medicine, University of Texas. M.D Anderson Cancer Center, Houston, TX, ²Rheumatology, Section for Autoimmune Diseases, Jiménez Díaz Foundation University Hospital, Madrid, Spain, ³General Internal Medicine, University of Texs, MD Anderson Cancer Center, Houston, TX, ⁴Internal Medicine, Louisiana State University Lafayette, Lafayette, LA, ⁵The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
Background/Purpose: In the era of modern medicine, radiotherapy remains a cornerstone for the multi-modality cancer treatment. Methods: We conducted a comprehensive search for any study…
Abstract Number: 699 • 2013 ACR/ARHP Annual Meeting
Severity Of Muscle Weakness Predicts Disability In Scleroderma
Julie J. Paik¹, Fredrick M. Wigley¹, Amanda Mejia² and Laura K. Hummers¹, ¹Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Biostatistics, Johns Hopkins Bloomberg School of Publich Health, Baltimore, MD
Title: Severity of muscle weakness predicts disability in scleroderma Background/Purpose: The Health assessment questionnaire disability index (HAQ-DI) is a self-administered questionnaire that is a patient…
Abstract Number: 700 • 2013 ACR/ARHP Annual Meeting
Osteoporosis and Fracture Risk In Outpatients With Systemic Sclerosis
Veronica Codullo¹, Flora Inverardi², Silvia Breda³, Laura Bogliolo⁴, Francesca De Nard⁵, Giovanni Cagnotto⁶, Roberto Caporali⁷ and Carlomaurizio Montecucco⁸, ¹Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, ²Rheumatology, Division of Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, ³Division of Rheumatology, University of Pavia, IRCCS Foundation Policlinico S. Matteo, Pavia, Italy, ⁴IRCCS Foundation Policlinico San Matteo, Pavia, Italy, ⁵University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, ⁶IRCCS Policlinico San Matteo, Pavia, Italy, ⁷Rheumatology, Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, ⁸Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
Background/Purpose: Osteoporosis (OP) is a frequent complication of a number of chronic inflammatory diseases. Only Rheumatoid Arthritis (RA) is included in the FRAX algorythm to…
Abstract Number: 701 • 2013 ACR/ARHP Annual Meeting
Extension Of Cardiac Damage Through The Delayed Enhancement Of Cardiac Magnetic Resonance: Predictive Value Of a Combined Approach Based On Clinical and Laboratory Findings, EKG-Holter and Cardiac Magnetic Resonance
Silvia Laura Bosello¹, Giacomo De Luca¹, Agostino Meduri², Giorgia Berardi¹, Manuela Rucco¹, Giovanni Canestrari¹, Federico Parisi¹ and Gianfranco Ferraccioli¹, ¹Division of Rheumatology, Institute of Rheumatology and Affine Sciences, Catholic University of the Sacred Heart, Rome, Italy, ²INSTITUTE OF RADIOLOGY - Catholic University of the Sacred Heart, ROME, Italy
Background/Purpose: Cardiac involvement is a relevant prognostic determinant in Systemic Sclerosis (SSc), but the diagnosis is often delayed due to the lack of a specific…
Abstract Number: 702 • 2013 ACR/ARHP Annual Meeting
Prediction Of Worsening Of Skin Fibrosis In Patients With Diffuse Systemic Sclerosis Using The EULAR Scleroderma Trials and Research (EUSTAR) Registry
Britta Maurer¹, Nicole Graf², Beat A. Michel³, Carola Metzig⁴, Vivian Lanius⁴, Dinesh Khanna⁵ and Oliver Distler¹, ¹Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland, ²graf biostatistics, Winterthur, Switzerland, ³Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, ⁴Bayer Pharma AG, Berlin, Germany, ⁵University of Michigan Health System, Ann Arbor, MI
Background/Purpose: To identify predictive parameters for the progression of skin fibrosis in patients with diffuse cutaneous SSc (dcSSc) to enable 1) risk-stratification in clinical practice…
Abstract Number: 703 • 2013 ACR/ARHP Annual Meeting
Correlation Between Patient Self-Report Of Symptoms Of Raynaud’s Phenomenon and Objective Assessment Of Digital Microvascular Perfusion Using Infrared Thermography
Marina Scolnik^1,2, Bhavisha Vasta², Darren Hart², Jacqueline A. Shipley², Sue Brown², Eleanor Korendowych², Neil J McHugh^2,3 and John D. Pauling^2,3, ¹Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ²Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, ³Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom
Background/Purpose: Patient self-report of digital colour changes form the basis of a clinical diagnosis of Raynaud's phenomenon (RP) and help classify patients with early systemic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].